Business

Q2 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.

Q2 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.

articleHob Biotech Group Corp., Ltd. Class AAugust 25, 20253/news/q2-2025-continuous-supervision-opinions-of-china-international-capital-corporation-limited-on-shuangrun-zhengan-information-consulting-beijing-co-ltds-tender-offer-to-acquire-jiangsu-hob-biotech-group-co-ltd
Q2 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.

About this update from Hob Biotech Group Corp., Ltd. Class A

Q2 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hob Biotech Group Corp., Ltd. Class A